2011 - Enoxaparin thrombophylaxis did not reduce mortality in acutely ill medical patients.
- Published in:
- ACP Journal Club, 2012, v. 156, n. 4, p. 5, doi. 10.7326/0003-4819-156-8-201204170-02006
- By:
- Publication type:
- Article
Works matching IS 10568751 AND DT 2012 AND VI 156 AND IP 4
Results: 12
1
2
2011 - Review: Statins reduce mortality and cardiovascular (CV) morbidity in patients with low CV risk.
- Published in:
- ACP Journal Club, 2012, v. 156, n. 4, p. 6, doi. 10.7326/0003-4819-156-8-201204170-02007
- By:
- Publication type:
- Article
3
2011 - CHADS2 score predicted bleeding and death in atrial fibrillation treated with anticoagulants.
- Published in:
- ACP Journal Club, 2012, v. 156, n. 4, p. 12, doi. 10.7326/0003-4819-156-8-201204170-02013
- By:
- Publication type:
- Article
4
2011 - The simplified Pulmonary Embolism Severity Index and high-sensitivity troponin T predicted prognosis in PE.
- Published in:
- ACP Journal Club, 2012, v. 156, n. 4, p. 11, doi. 10.7326/0003-4819-156-8-201204170-02012
- By:
- Publication type:
- Article
5
2011 - Thiazides increased hyponatremia, but not hospitalizations, in patients with hypertension.
- Published in:
- ACP Journal Club, 2012, v. 156, n. 4, p. 10, doi. 10.7326/0003-4819-156-8-201204170-02011
- By:
- Publication type:
- Article
6
2011 - Ivacaftor improved lung function in cystic fibrosis with G551D mutation.
- Published in:
- ACP Journal Club, 2012, v. 156, n. 4, p. 9, doi. 10.7326/0003-4819-156-8-201204170-02010
- By:
- Publication type:
- Article
7
2011 - Review: Fidaxomicin is better than vancomycin for Clostridium difficile recurrence.
- Published in:
- ACP Journal Club, 2012, v. 156, n. 4, p. 8, doi. 10.7326/0003-4819-156-8-201204170-02009
- By:
- Publication type:
- Article
8
2011 - Adding niacin to simvastatin did not improve clinical outcomes in patients with CV disease and dyslipidemia.
- Published in:
- ACP Journal Club, 2012, v. 156, n. 4, p. 7, doi. 10.7326/0003-4819-156-8-201204170-02008
- By:
- Publication type:
- Article
9
2011 - Radiation plus androgen deprivation therapy reduced mortality in locally advanced prostate cancer.
- Published in:
- ACP Journal Club, 2012, v. 156, n. 4, p. 4, doi. 10.7326/0003-4819-156-8-201204170-02005
- By:
- Publication type:
- Article
10
2011 - Review: Androgen deprivation therapy does not increase CV mortality in prostate cancer.
- Published in:
- ACP Journal Club, 2012, v. 156, n. 4, p. 3, doi. 10.7326/0003-4819-156-8-201204170-02004
- By:
- Publication type:
- Article
11
Radical prostatectomy and watchful waiting for localized prostate cancer did not differ for quality of life.
- Published in:
- ACP Journal Club, 2012, v. 156, n. 4, p. 2, doi. 10.7326/0003-4819-156-8-201204170-02003
- By:
- Publication type:
- Article
12
2011 - Review: PSA-based screening does not reduce prostate cancer mortality or all-cause mortality.
- Published in:
- ACP Journal Club, 2012, v. 156, n. 4, p. 1, doi. 10.7326/0003-4819-156-8-201204170-02002
- By:
- Publication type:
- Article